Continued R&D Activities
First written in FY2017-Q1. 23 of 28 entries say "Restated". Latest entry: FY2026.
Musashi moved to the "Worse" side of this theme in 2026.
3 other companies' latest entry also says "Softened".
- FY2026SoftenedAnnual report
「Total R&D expenses for the current consolidated fiscal year amounted to ¥235 million.」
The R&D focus and collaboration policy remain in place, while R&D expenses decreased from ¥532 million in the previous fiscal year to ¥235 million. - FY2026-H1RestatedAnnual report
「Total R&D expenses for the current interim consolidated period amounted to ¥115 million. There were no material changes in the status of the Group's R&D activities during the period.」
The policy of making no material changes to R&D activities remains in place. R&D expenses for the interim period are stated as ¥115 million. - FY2025AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year amounted to ¥532 million.」
While maintaining the R&D focus, R&D expenses increased from ¥353 million in the previous fiscal year to ¥532 million. - FY2024AdvancedAnnual report
「The planning and development of proprietary products focuses on thermal expansion printers in the Information, Printing and Industrial Systems Equipment segment; currency-processing equipment, security equipment and election equipment in the Financial Equipment and Election Systems Equipment segment; and pressure-sensitive paper in the Paper and Paper Products segment. Total R&D expenses for the current consolidated fiscal year amounted to ¥353 million.」
The R&D focus remains unchanged, while R&D expenses increased from ¥220 million in the previous fiscal year to ¥353 million. - FY2024-Q2RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the six months ended the second quarter was ¥148 million. There were no material changes in the status of the Group’s research and development activities during the six months ended the second quarter.」
The explanation that there were no material changes in R&D activities continues. Cumulative R&D expenses are stated as ¥148 million. - FY2024-Q1RestatedAnnual report
「Group-wide R&D expenses for the first quarter of the current consolidated cumulative period amounted to ¥1 million. There were no material changes in the status of the Group's R&D activities during the period.」
The explanation that there were no material changes in R&D activities continues. R&D expenses are stated as ¥1 million. - FY2023-Q3RestatedAnnual report
「Group-wide R&D expenses for the first three quarters of the current consolidated cumulative period amounted to ¥77 million. There were no material changes in the status of the Group's R&D activities during the period.」
The policy of making no material changes to R&D activities remains in place. Cumulative R&D expenses are stated as ¥77 million. - FY2023-Q1RestatedAnnual report
「The Group's total research and development activities during the three-month period ended the first quarter amounted to ¥4 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended the first quarter.」
The policy of making no material changes to R&D activities remains in place. R&D expenses are stated as ¥4 million. - FY2022-Q3RestatedAnnual report
「Group-wide R&D expenses for the first three quarters of the current consolidated cumulative period amounted to ¥86 million. There were no material changes in the status of the Group's R&D activities during the period.」
The policy of making no material changes to R&D activities remains in place. Cumulative R&D expenses are stated as ¥86 million. - FY2022-Q2RestatedAnnual report
「Group-wide R&D expenses for the first half of the current consolidated cumulative period amounted to ¥81 million. There were no material changes in the status of the Group's R&D activities during the period.」
The explanation that there were no material changes in R&D activities continues. Cumulative R&D expenses are stated as ¥81 million. - FY2022-Q1RestatedAnnual report
「The Group's total research and development expenditure for the cumulative consolidated first-quarter period was ¥12 million. There were no material changes in the status of the Group's research and development activities during the cumulative consolidated first-quarter period.」
The explanation that there were no material changes in R&D activities continues. R&D expenses are stated as ¥12 million. - FY2021AdvancedAnnual report
「The planning and development of proprietary products focuses on thermal expansion printers in the Information, Printing and Industrial Systems Equipment segment; currency-processing equipment, security equipment and election equipment in the Financial Equipment and Election Systems Equipment segment; and pressure-sensitive paper in the Paper and Paper Products segment. Total R&D expenses for the current consolidated fiscal year amounted to ¥165 million.」
The R&D focus has been specified as thermal expansion printers, currency-processing, security and election equipment, and pressure-sensitive paper. Annual R&D expenses of ¥165 million are stated. - FY2021-Q3RestatedAnnual report
「Group-wide R&D expenses for the first three quarters of the current consolidated cumulative period amounted to ¥88 million. There were no material changes in the status of the Group's R&D activities during the period.」
The policy of making no material changes to R&D activities remains in place. R&D expenses are stated as ¥88 million. - FY2021-Q2RestatedAnnual report
「Group-wide R&D expenses for the first half of the current consolidated cumulative period amounted to ¥81 million. There were no material changes in the status of the Group's R&D activities during the period.」
The policy of making no material changes to R&D activities remains in place. R&D expenses are stated as ¥81 million. - FY2021-Q1RestatedAnnual report
「The group-wide amount spent on research and development activities during the cumulative first quarter was ¥15 million. There were no material changes in the status of the group's research and development activities during the cumulative first quarter.」
The policy of making no material changes to R&D activities remains in place. R&D expenses are stated as ¥15 million. - FY2020-Q3RestatedAnnual report
「The Group's total research and development expenditure for the cumulative consolidated period through the third quarter was ¥68 million. There were no material changes in the status of the Group's research and development activities during the period.」
The explanation that there were no material changes in R&D activities continues. R&D expenses are stated as ¥68 million. - FY2020-Q2RestatedAnnual report
「Group-wide R&D expenses for the first half of the current consolidated cumulative period amounted to ¥62 million. There were no material changes in the status of the Group's R&D activities during the period.」
The explanation that there were no material changes in R&D activities continues. Cumulative R&D expenses are stated as ¥62 million. - FY2020-Q1RestatedAnnual report
「Group-wide R&D expenses for the first quarter of the current consolidated cumulative period amounted to ¥6 million. There were no material changes in the status of the Group's R&D activities during the period.」
The explanation that there were no material changes in R&D activities continues. R&D expenses are stated as ¥6 million. - FY2019-Q3RestatedAnnual report
「The Group's total research and development expenditure for the cumulative consolidated period through the third quarter was ¥84 million. There were no material changes in the status of the Group's research and development activities during the period.」
The explanation that there were no material changes in R&D activities continues. R&D expenses are stated as ¥84 million. - FY2019-Q2RestatedAnnual report
「Group-wide R&D expenses for the first half of the current consolidated cumulative period amounted to ¥37 million. There were no material changes in the status of the Group's R&D activities during the period.」
The explanation that there were no material changes in R&D activities continues. R&D expenses are stated as ¥37 million. - FY2019-Q1RestatedAnnual report
「Group-wide R&D expenses for the first quarter of the current consolidated cumulative period amounted to ¥5 million. There were no material changes in the status of the Group's R&D activities during the period.」
The explanation that there were no material changes in R&D activities continues. R&D expenses are stated as ¥5 million. - FY2018-Q3RestatedAnnual report
「The group’s research and development expenditure for the cumulative third quarter period was ¥53 million. There were no material changes in the status of the group’s research and development activities during the cumulative third quarter period.」
The explanation that there were no material changes in R&D activities continues. R&D expenses are stated as ¥53 million. - FY2018-Q2RestatedAnnual report
「Group-wide R&D activities during the six-month period ended Q2 amounted to ¥34 million. There were no significant changes in the status of the Group's R&D activities during the six-month period ended Q2.」
The explanation that there were no material changes in R&D activities continues. R&D expenses are stated as ¥34 million. - FY2018-Q1RestatedAnnual report
「Group-wide R&D expenses for the first quarter of the current consolidated cumulative period amounted to ¥10 million. There were no material changes in the status of the Group's R&D activities during the period.」
The explanation that there were no material changes in R&D activities continues. R&D expenses are stated as ¥10 million. - FY2017RestatedAnnual report
「The Group's R&D activities focus on planning and developing new products and improving and enhancing existing products. In particular, the planning and development of proprietary products centers on currency-processing equipment, security equipment and election equipment. The Group analyzes and explores customers' operating environments and needs and works to create and provide optimal equipment and systems. Total R&D expenses for the current consolidated fiscal year amounted to ¥122 million.」
The R&D policy remains focused on developing new products and improving existing products. - FY2017-Q3RestatedAnnual report
「Group-wide R&D expenses for the first three quarters of the current consolidated cumulative period amounted to ¥62 million. There were no material changes in the status of the Group's R&D activities during the period.」
The explanation that there were no material changes in R&D activities continues. Cumulative R&D expenses are stated as ¥62 million. - FY2017-Q2RestatedAnnual report
「The Group's total research and development expenditure for the cumulative consolidated period through the second quarter was ¥55 million. There were no material changes in the status of the Group's research and development activities during the period.」
The policy of making no material changes to R&D activities remains in place. R&D expenses for the cumulative period are stated as ¥55 million. - FY2017-Q1First statedAnnual report
「Group-wide R&D expenses for the first quarter of the current consolidated cumulative period amounted to ¥5 million. There were no material changes in the status of the Group's R&D activities during the period.」
States that R&D expenses were ¥5 million and that there were no material changes in R&D activities.